Tilray Should Benefit from 2H Cannabis Recovery, BrewDog Buy

Dow Jones10-10

1246 ET - Tilray Brands still has work to do in its legacy beverage and adult-use cannabis business, but there are green shoots of improvement, according to TD Cowen's Derek Lessard. In a report, the analyst notes that the company is making progress against its key priorities, and that "we are encouraged by the early performance of its new cannabis strains, alongside improving BrewDog demand and margins." It is still early days for these new additions. "While these trends are still developing, they give us greater confidence in TLRY's longer-term growth outlook," Lessard says. He expects recreational cannabis to return to growth in 2H, while the recent acquisition of BrewDog should help lift overall margins above its legacy average.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment